[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 17, 2007

Raloxifene vs Tamoxifen—Reply

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;297(3):263-264. doi:10.1001/jama.297.3.264-a

In Reply: In our Editorial, we focused on breast cancer chemoprevention as the basis of therapy. Dr Goldstein illustrates that there are individual cases in which raloxifene is a superior choice of therapy. Similarly, there are cases in which tamoxifen may be a better choice. Patient preference and issues related to cost or confidence in the long-term sequelae of tamoxifen therapy may influence a patient to choose, with her physician, tamoxifen over raloxifene.

First Page Preview View Large
First page PDF preview
First page PDF preview
×